We welcome all interested parties to a workshop on human papiloma viruses (HPV) and associated neoplastic diseases and cancer.

Participation

All Rīga Stradiņš University (RSU) researchers who are working on HPV infection and associated cancers are invited to submit presentations - we have slots in the research program and especially welcome early-career researchers.

If you wish to participate with a presentation, please email Lība Sokolovska (liba[pnkts]sokolovskarsu[pnkts]lv, cc: maria[pnkts]issagouliantisrsu[pnkts]lv, issagouliantis@gmail,com) and include your affiliation, contact email, and phone nr, and eventual presentation title in English. Presentations must be submitted by 14 December (17.00). The duration of presentations should be 10-15 min. Please, note that both the number of speaker slots and the overall number participants is limited.

Programme

RSU Senate Hall (K-212) Dzirciema iela, 16, Rīga

RESEARCH PART 16.00-17.30 (in English)

Opening
Prof. Gunta Lazdāne (RSU)

• Maria Issagouliantis (RSU) - "Presentation of the aims, tasks and development of the project on human papillomavirus (HPV) genome associated correlates of disease progression and treatment response for cervical neoplasms and cancer" (LZP 2021/1-0484) (15 min)
• Arta Spridzāne (RSU, RAKUS) – "Progress of prospective and retroprospective screening of women for cervical pathologies and high risk HPV (HR HPV) infection with socio demographic correlates" (15 min)
• Lība Sokolovska (RSU) – "Cross-sectional study of the prevalence of HR HPVs in cervical cancer cases in Riga 2016-2023" (15 min)
• Juris Jansons (RSU, BMC) - "HPV16 oncoproteins E6 and E7 as immunogens for therapeutic HPV vaccines with experimental studies in mice" (15 min)

Reception & mingle with our patients 17.30 – 18.00 

POPULAR SCIENCE PART 18.00-19.00 (in Latvian)

Opening
Dr. Androniks Mitildzāns, Dr. Arta Spridzāne, Dr. Jurijs Nazarovs

Prof. Gunta Ladzāne - "The problem of cervical cancer, its association with papilloma virus infection" (20 min)

Short presentations by specialists:

• Screening to detect neoplasia and cancer - how, when, how effective it is
• Diagnostic methods to detect cervical infections and diseases
• Prophylactic vaccines against papilloma virus infection - presentation of vaccines and vaccination programs, when it is given, what is the long-term effect, are there any side effects?
• Ways to treat cervical neoplasia and cancer

Q&A

sign up here to attend the seminar

“Human papillomavirus genome associated correlates of disease progression and treatment response for cervical neoplasms and cancer” (lzp-2021/1-0484)